Olema Pharmaceuticals, Inc.
OLMA
$5.59
-$0.17-2.95%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 361.91M | 392.71M | 434.09M | 214.76M | 239.10M |
| Total Receivables | 2.75M | 1.92M | 2.12M | 687.00K | 821.00K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 2.64M | 1.76M | 1.90M | 2.36M | 2.09M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 423.00K | 276.00K | 366.00K | 188.00K | 171.00K |
| Total Current Assets | 367.73M | 396.66M | 438.47M | 217.99M | 242.19M |
|
|
|||||
| Total Current Assets | 367.73M | 396.66M | 438.47M | 217.99M | 242.19M |
| Net Property, Plant & Equipment | 2.25M | 1.71M | 2.06M | 2.42M | 2.76M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 12.03M | 11.27M | 10.45M | 9.76M | 9.61M |
| Total Assets | 382.00M | 409.64M | 450.98M | 230.17M | 254.56M |
|
|
|||||
| Total Accounts Payable | 934.00K | 151.00K | 4.46M | 2.69M | 4.35M |
| Total Accrued Expenses | 31.08M | 24.89M | 36.09M | 26.81M | 21.02M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 1.15M | 1.03M | 1.17M | 1.14M | 1.10M |
| Total Finance Division Other Current Liabilities | -- | -- | 41.00K | 72.00K | 61.00K |
| Total Other Current Liabilities | -- | -- | 41.00K | 72.00K | 61.00K |
| Total Current Liabilities | 33.16M | 26.06M | 41.76M | 30.70M | 26.54M |
|
|
|||||
| Total Current Liabilities | 33.16M | 26.06M | 41.76M | 30.70M | 26.54M |
| Long-Term Debt | 3.00M | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 602.00K | 123.00K | 257.00K | 562.00K | 859.00K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 36.77M | 26.19M | 42.02M | 31.26M | 27.39M |
|
|
|||||
| Common Stock & APIC | 854.20M | 848.53M | 843.93M | 599.99M | 594.27M |
| Retained Earnings | -509.28M | -465.50M | -435.11M | -401.54M | -366.98M |
| Treasury Stock & Other | 314.00K | 420.00K | 143.00K | 464.00K | -118.00K |
| Total Common Equity | 345.24M | 383.45M | 408.96M | 198.91M | 227.16M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 345.24M | 383.45M | 408.96M | 198.91M | 227.16M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 345.24M | 383.45M | 408.96M | 198.91M | 227.16M |
|
|
|||||